vs

Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $37.2M, roughly 1.9× Organogenesis Holdings Inc.). On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs -57.1%). Over the past eight quarters, MEDALLION FINANCIAL CORP's revenue compounded faster (15.0% CAGR vs -46.5%).

Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

MFIN vs ORGO — Head-to-Head

Bigger by revenue
MFIN
MFIN
1.9× larger
MFIN
$70.6M
$37.2M
ORGO
Growing faster (revenue YoY)
MFIN
MFIN
+82.5% gap
MFIN
25.4%
-57.1%
ORGO
Faster 2-yr revenue CAGR
MFIN
MFIN
Annualised
MFIN
15.0%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MFIN
MFIN
ORGO
ORGO
Revenue
$70.6M
$37.2M
Net Profit
$12.2M
Gross Margin
30.8%
Operating Margin
29.3%
-185.1%
Net Margin
17.3%
Revenue YoY
25.4%
-57.1%
Net Profit YoY
20.3%
EPS (diluted)
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MFIN
MFIN
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$70.6M
$225.6M
Q3 25
$58.7M
$150.9M
Q2 25
$62.6M
$101.0M
Q1 25
$63.0M
$86.7M
Q4 24
$56.3M
$126.7M
Q3 24
$53.3M
$115.2M
Q2 24
$51.0M
$130.2M
Net Profit
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
$12.2M
$43.7M
Q3 25
$7.8M
$21.6M
Q2 25
$11.1M
$-9.4M
Q1 25
$12.0M
$-18.8M
Q4 24
$10.1M
$7.7M
Q3 24
$8.6M
$12.3M
Q2 24
$7.1M
$-17.0M
Gross Margin
MFIN
MFIN
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
MFIN
MFIN
ORGO
ORGO
Q1 26
-185.1%
Q4 25
29.3%
28.1%
Q3 25
33.2%
13.7%
Q2 25
31.1%
-12.5%
Q1 25
32.1%
-30.9%
Q4 24
32.8%
8.1%
Q3 24
26.6%
5.4%
Q2 24
24.3%
-10.7%
Net Margin
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
17.3%
19.4%
Q3 25
13.2%
14.3%
Q2 25
17.7%
-9.3%
Q1 25
19.1%
-21.7%
Q4 24
18.0%
6.1%
Q3 24
16.1%
10.7%
Q2 24
13.9%
-13.1%
EPS (diluted)
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
$0.50
$0.31
Q3 25
$0.32
$0.11
Q2 25
$0.46
$-0.10
Q1 25
$0.50
$-0.17
Q4 24
$0.43
$0.05
Q3 24
$0.37
$0.09
Q2 24
$0.30
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MFIN
MFIN
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$136.3M
$91.4M
Total DebtLower is stronger
$216.0M
Stockholders' EquityBook value
$408.6M
Total Assets
$3.0B
$520.0M
Debt / EquityLower = less leverage
0.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MFIN
MFIN
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$136.3M
$93.7M
Q3 25
$72.5M
$63.7M
Q2 25
$110.4M
$73.1M
Q1 25
$131.5M
$110.0M
Q4 24
$98.2M
$135.6M
Q3 24
$120.6M
$94.3M
Q2 24
$87.7M
$89.9M
Total Debt
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
$216.0M
Q3 25
$215.7M
Q2 25
$199.9M
Q1 25
$199.7M
Q4 24
$232.2M
Q3 24
$232.0M
$62.3M
Q2 24
$230.8M
$63.8M
Stockholders' Equity
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
$408.6M
$300.1M
Q3 25
$397.4M
$255.1M
Q2 25
$389.9M
$233.2M
Q1 25
$380.2M
$242.9M
Q4 24
$370.2M
$262.9M
Q3 24
$362.4M
$278.5M
Q2 24
$354.0M
$263.5M
Total Assets
MFIN
MFIN
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$3.0B
$598.7M
Q3 25
$2.9B
$509.8M
Q2 25
$2.9B
$461.1M
Q1 25
$2.8B
$467.4M
Q4 24
$2.9B
$497.9M
Q3 24
$2.9B
$446.3M
Q2 24
$2.8B
$443.2M
Debt / Equity
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
0.53×
Q3 25
0.54×
Q2 25
0.51×
Q1 25
0.53×
Q4 24
0.63×
Q3 24
0.64×
0.22×
Q2 24
0.65×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MFIN
MFIN
ORGO
ORGO
Operating Cash FlowLast quarter
$126.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
10.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
$126.3M
$39.4M
Q3 25
$67.0M
$3.1M
Q2 25
$-10.7M
$-32.9M
Q1 25
$36.3M
$-19.9M
Q4 24
$108.7M
$10.9M
Q3 24
$24.6M
$8.7M
Q2 24
$27.6M
$4.7M
Free Cash Flow
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
MFIN
MFIN
ORGO
ORGO
Q1 26
Q4 25
10.35×
0.90×
Q3 25
8.63×
0.14×
Q2 25
-0.97×
Q1 25
3.02×
Q4 24
10.72×
1.43×
Q3 24
2.86×
0.71×
Q2 24
3.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons